Statins as Potential Chemoprevention or Therapeutic Agents in Cancer: a Model for Evaluating Repurposed Drugs
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-6269
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Statins as Potential Chemoprevention or Therapeutic Agents in Cancer: a Model for Evaluating Repurposed Drugs ; volume:23 ; number:3 ; day:13 ; month:2 ; year:2021 ; pages:1-13 ; date:3.2021
Current oncology reports ; 23, Heft 3 (13.2.2021), 1-13, 3.2021
- Urheber
-
Joharatnam-Hogan, Nalinie
Alexandre, Leo
Yarmolinsky, James
Lake, Blossom
Capps, Nigel
Martin, Richard M.
Ring, Alistair
Cafferty, Fay
Langley, Ruth E.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11912-021-01023-z
- URN
-
urn:nbn:de:101:1-2021050616310203336563
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Joharatnam-Hogan, Nalinie
- Alexandre, Leo
- Yarmolinsky, James
- Lake, Blossom
- Capps, Nigel
- Martin, Richard M.
- Ring, Alistair
- Cafferty, Fay
- Langley, Ruth E.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Targeting AMPK by Statins: A Potential Therapeutic Approach
Selecting women for breast cancer chemoprevention and what agents should be used
Biomarkers in cancer chemoprevention
Natural Products for Chemoprevention
Statins in Females
Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins
Emerging therapeutic agents for genitourinary cancers
Emerging therapeutic agents for lung cancer
Are statins anti-inflammatory?
Hepatotoxicity associated with statins
Evaluating embodied conversational agents in multimodal interfaces
Independent association of Lp(a) with platelet reactivity in subjects without statins or antiplatelet agents
Targeting AMPK by Statins: A Potential Therapeutic Approach
Selecting women for breast cancer chemoprevention and what agents should be used
Biomarkers in cancer chemoprevention
Natural Products for Chemoprevention
Statins in Females
Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins
Emerging therapeutic agents for genitourinary cancers
Emerging therapeutic agents for lung cancer
Are statins anti-inflammatory?
Hepatotoxicity associated with statins
Evaluating embodied conversational agents in multimodal interfaces
Independent association of Lp(a) with platelet reactivity in subjects without statins or antiplatelet agents
Targeting AMPK by Statins: A Potential Therapeutic Approach
Selecting women for breast cancer chemoprevention and what agents should be used
Biomarkers in cancer chemoprevention
Natural Products for Chemoprevention
Statins in Females
Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins
Emerging therapeutic agents for genitourinary cancers
Emerging therapeutic agents for lung cancer
Are statins anti-inflammatory?
Hepatotoxicity associated with statins
Evaluating embodied conversational agents in multimodal interfaces